| ASSET | YEAR | % RETURN |
|---|---|---|
AXT (AXTI) | 2026 | 568.49% |
Aehr Test Systems (AEHR) | 2026 | 405.9% |
MaxLinear (MXL) | 2026 | 397.92% |
Lightwave Logic (LWLG) | 2026 | 359.38% |
Immunitybio (IBRX) | 2026 | 303.47% |
Ichor (ICHR) | 2026 | 288.28% |
Ultra Clean (UCTT) | 2026 | 230.45% |
Babcock & Wilcox Enterprises (BW) | 2026 | 226.46% |
Veradermics (MANE) | 2026 | 211.97% |
POET Technologies (POET) | 2026 | 208.86% |
Navitas Semiconductor (NVTS) | 2026 | 197.6% |
Tango Therapeutics (TNGX) | 2026 | 181.02% |
Silicon Motion Technology (SIMO) | 2026 | 180.7% |
Erasca (ERAS) | 2026 | 179.51% |
Enliven Therapeutics (ELVN) | 2026 | 177.94% |
Vishay Intertechnology (VSH) | 2026 | 157.64% |
Alumis (ALMS) | 2026 | 152.1% |
Himax Technologies (HIMX) | 2026 | 150.06% |
Iridium Communications (IRDM) | 2026 | 149.39% |
Penguin Solutions (PENG) | 2026 | 148.69% |
Nanobiotix (NBTX) | 2026 | 142.49% |
Day One Biopharmaceuticals (DAWN) | 2026 | 131.75% |
Spyre Therapeutics (SYRE) | 2026 | 130.92% |
Kulicke and Soffa Industries (KLIC) | 2026 | 123.06% |
Intuitive Machines (LUNR) | 2026 | 117.77% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.